, Lu, Y. ., Highland, H. ., Schürmann, C. ., Justice, A. ., Fine, R. ., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 766-767. https://doi.org/10.1038/s41588-018-0082-3
JC Tardif
First name:
JC
Last name:
Tardif
, Lu, Y. ., Highland, H. ., Schürmann, C. ., Justice, A. ., Fine, R. ., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 765-766. https://doi.org/10.1038/s41588-018-0050-y
, Lu, Y. ., Highland, H. ., Schürmann, C. ., Justice, A. ., Fine, R. ., … Scientific, G. U. S. (2018). Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(1), 26-41. https://doi.org/10.1038/s41588-017-0011-x
Marouli, E. ., Graff, M. ., Medina-Gomez, C. ., Lo, K. ., Wood, A. ., Kjaer, T. ., … Lettre, G. . (2017). Rare and low-frequency coding variants alter human adult height. Nature, 542(7640), 186-190. https://doi.org/10.1038/nature21039 (Original work published 2017)
Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., Ketchum, S. ., … REDUCE-IT, I. . (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)
Ridker, P. ., Revkin, J. ., Amarenco, P. ., Brunell, R. ., Curto, M. ., Civeira, F. ., … Outcome, I. S. C. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376(16), 1527-1539. https://doi.org/10.1056/NEJMoa1701488 (Original work published 2017)
Verma, S. ., Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., … REDUCE-IT, I. . (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)
